 |
 |
|
|
|
|
|
|
|
Tremendous growth : potential seen in China's ophthalmic market |
| Daisy Zhang, Asia Manufacturing Pharma |
|
China's ophthalmic market is believed to have tremendous growth potential, with the gradual improvement of the country's medical system and the rapid development of the market economy.
As the old adage goes, "the eyes are the windows to the soul". People tend to pay particular attention to their eyesight, enabling ophthalmic drugs to quickly gain a larger market share. Given the positive outlook for the ophthalmic market, more and more pharmaceutical companies worldwide have become engaged in the manufacturing of ophthalmic drugs.
|
|
|
|
|
|
|
|
|
|
|
|
Takeda Pharmaceuticals and TAP Pharmaceutical Products Inc. Merge |
|
|
Takeda Pharmaceutical Company Limited today announced that Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. merged with TAP Pharmaceutical Products Inc. (TAP), forming one of the top 15 pharmaceutical companies in the United States.
|
|
|
|
|
|
Pfizer and Ranbaxy Settle Lipitor Patent Litigation Worldwide |
|
|
Pfizer Inc announced today that it has entered into an agreement with generics manufacturer Ranbaxy Laboratories Ltd. of India and certain of its affiliates to settle substantially all their patent litigation worldwide involving Lipitor, the world’s most-prescribed cholesterol-lowering medicine.
|
|
|
|
|
|
|
|
|
| PERSPECTIVES |
|
|
|
|
Do you know how the Japanese Pharmaceutical Industry Operates? |
|
This months Perspectives provides both an historical and current viewpoint into the Japanese Pharmaceutical Industry and its Laws. Providing an insight as to which departments are responsible for Japanese legislative decisions and procedures, regulatory affairs, the growth of pharmaceutical law, drug manufacturing, distribution, licensing all the way to patent law.
|
|
|
| PRODUCTS OF THE MONTH |
|
|
|
|
Alpha and Powder Round |
|
Saint-Gobain Desjonquères (SGD) is now one of the major pharmaceutical glass makers in the world. Not only is SGD one of the major glass manufacturers in the world, they are the only pharmaceutical manufacturer in the world to have a consistent strategy to achieve ISO 15378 by AFAQ for all of SGD manufacturing sites world wide, which was achieved in 2007.
|
|
|
|
|
|
|
|
